Keyphrases
Prospective Randomized Trial
100%
Blinded Trial
100%
Venous Leg Ulcer
100%
Wound Healing Agent
100%
Placebo
66%
Silver Sulfadiazine
66%
Wound Healing
33%
Healing
33%
Keratinocytes
33%
Biologically Active
33%
Anti-inflammatory Properties
33%
Recurrence Rate
33%
Patient-completed
33%
Nonoperative
33%
Tripeptide
33%
Ulcer
33%
Epithelization
33%
Chronic Wounds
33%
Initial Management
33%
Bacterial Levels
33%
Socioeconomic Issues
33%
Ulcer Size
33%
Cream Formulation
33%
Antibacterial Action
33%
Silver Sulfadiazine Cream
33%
Copper Complex
33%
Nursing and Health Professions
Ulcer
100%
Wound Healing Promoting Agent
100%
Venous Stasis
100%
Silver Sulfadiazine
75%
Cream
75%
Placebo
50%
Wound Healing
25%
Wound
25%
Recurrence Risk
25%
Chronic Wound
25%
Antiinfective Agent
25%
Copper Complex
25%
Tripeptide
25%
Medicine and Dentistry
Ulcer
100%
Venous Stasis
100%
Wound Healing Promoting Agent
100%
Sulfadiazine Silver
75%
Placebo
50%
Wound
25%
Wound Healing
25%
Antiinfective Agent
25%
Recurrence Risk
25%
Epithelization
25%
Chronic Wound
25%
Copper Complex
25%
Tripeptide
25%
Keratinocyte
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ulcer
100%
Wound Healing Promoting Agent
100%
Venous Stasis
100%
Silver Sulfadiazine
75%
Placebo
50%
Wound
25%
Wound Healing
25%
Antiinfective Agent
25%
Recurrence Risk
25%
Chronic Wound
25%
Copper Complex
25%
Tripeptide
25%